Frank H Ardesch, Rose J Geurten, Jeroen N Struijs, Dirk Ruwaard, Henk J G Bilo, Arianne M J Elissen
{"title":"Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands.","authors":"Frank H Ardesch, Rose J Geurten, Jeroen N Struijs, Dirk Ruwaard, Henk J G Bilo, Arianne M J Elissen","doi":"10.1016/j.pcd.2024.12.011","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.011","url":null,"abstract":"<p><strong>Aims: </strong>This study aims to analyze prescription patterns of new diabetes medication and assess socioeconomic disparities in their initiation among individuals with T2DM with very high cardiovascular risk.</p><p><strong>Methods: </strong>Individuals diagnosed with T2DM and very high cardiovascular risk were identified (N = 10,768) based on general practitioner's electronic health record data. SGLT-2is and GLP-1RAs prescription patterns were examined. Furthermore, the association between SES and the prescription of SGLT-2is and GLP-1RAs in 2022 was investigated.</p><p><strong>Results: </strong>Despite the increase in prescription rates of SGLT-2is and GLP-1RAs between 2019 and 2022, approximately 85 % and 93 % of eligible individuals did not receive SGLT-2is and GLP-1RAs in 2022, respectively. We found a positive association between SGLT-2is prescription and SES in only the 4th quintile compared to 1st quintile (referent) in the fully adjusted model (OR 1.29 95 % CI:1.08-1.54).</p><p><strong>Conclusions: </strong>The prescription rates among eligible individuals highlight significant room for improvement in aligning prescribing practices with guidelines. We found no profound socioeconomic gradient in initiation of SGLT-2is and GLP-1RAs. The latter may be due to guidelines' clear indication of the eligible population and GP education. Future development and potential disparities in initiation and maintenance should be monitored to ensure equitable prescribing.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Esther Seidel-Jacobs, Fiona Kohl, Joachim Rosenbauer, Matthias B Schulze, Oliver Kuss, Wolfgang Rathmann
{"title":"Effect of applying a diabetes risk score on lifestyle counselling and shared decision-making in primary care: A pragmatic cluster randomised trial.","authors":"Esther Seidel-Jacobs, Fiona Kohl, Joachim Rosenbauer, Matthias B Schulze, Oliver Kuss, Wolfgang Rathmann","doi":"10.1016/j.pcd.2024.12.009","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.009","url":null,"abstract":"<p><strong>Aims: </strong>There is a lack of studies on the impact of diabetes risk scores on diabetes prevention. The aim of this study was to investigate the effect of applying a non-invasive diabetes risk score as component of routine health checks on counselling intensity and shared decision-making (SDM) in primary care.</p><p><strong>Methods: </strong>Cluster randomised trial, in which primary care physicians (n = 30) enrolled participants (n = 315) with statutory health insurance without known diabetes, ≥ 35 years of age with a body mass index (BMI) ≥ 27.0 kg/m<sup>2</sup>. In the intervention group, the German Diabetes Risk Score (GDRS) was applied as add-on to the standard routine health check. Outcomes were length and intensity of the counselling interview and the process of SDM. Analysis was by intention-to-treat using mixed models.</p><p><strong>Results: </strong>In the intervention group, higher odds were found for a more intensive counselling interview regarding physical activity, healthy diet and body weight (e.g., participants` perspective: odds ratios between 1.8 and 2.5) compared to controls. Analysis of total SDM score showed a more participative counselling interview in the intervention than in the control group.</p><p><strong>Conclusions: </strong>GDRS use in routine primary care improves intensity of lifestyle counselling and process of SDM already in people with moderate diabetes risk.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D Orozco-Beltran, M Mata-Cases, S Artola-Menéndez, F Álvarez-Guisasola, A M Cebrián-Cuenca, A Pérez
{"title":"Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care.","authors":"D Orozco-Beltran, M Mata-Cases, S Artola-Menéndez, F Álvarez-Guisasola, A M Cebrián-Cuenca, A Pérez","doi":"10.1016/j.pcd.2024.12.002","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.002","url":null,"abstract":"<p><strong>Aims: </strong>To analyze glycemic and bodyweight control in people with type 2 diabetes mellitus (T2DM), and prescribing patterns in primary care.</p><p><strong>Methods: </strong>We reviewed the electronic medical records of 5009 randomly selected T2DM patients, from 70 health centers in Spain. We analyzed results by age group and presence/absence of obesity. All data were collected in 2022.</p><p><strong>Results: </strong>Regarding treatment, 13.2 % of the sample were on lifestyle therapy only, 76.5 % received metformin, 37.6 % SGLT2 inhibitors, 32.2 % DPP-4 inhibitors, 12.2 % GLP-1 agonists, 18.9 % insulin, 6.5 % sulfonylureas, and 1.3 % glitazones. Glycated Hemoglobin (HbA1c) was below 7 % in 57.7 % of patients, and 62.3 % met their individualized HbA1c targets. Overall, 42 % of the population was obese (45.6 % of women vs 39.1 % of men; p = 0.001). Obesity rates decreased with age in both sexes. We found no association between obesity and poor glycemic control (HbA1c<7 %) (43,5 % vs 41,4 %; p = 0,17).</p><p><strong>Conclusions: </strong>In 2022, over 60 % of people with T2DM treated by family doctors in Spain met their individualized glycemic control targets, but only one in three had good glycemic control without obesity. The use of drugs with cardiorenal benefits (particularly SGLT2 inhibitors) is higher than previous published data in our setting.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142911222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Blaya Fernández, Alba Gracia-Sánchez, Sara Zúnica-García, Esther Chicharro-Luna
{"title":"Assessment of healthcare utilization in diabetes patients according to foot risk level.","authors":"Cristina Blaya Fernández, Alba Gracia-Sánchez, Sara Zúnica-García, Esther Chicharro-Luna","doi":"10.1016/j.pcd.2024.12.005","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.005","url":null,"abstract":"<p><strong>Aims: </strong>To quantify healthcare service utilization over the past two years according to the foot risk level in patients with type 2 diabetes (T2DM).</p><p><strong>Methodology: </strong>A descriptive observational study was conducted in a Primary Care Nursing consultation, evaluating patients with T2DM through examination and collection of sociodemographic and clinical data.</p><p><strong>Results: </strong>A total of 153 patients were included. The prevalence of underdiagnosis was 71.2 % for neuropathy and 59.5 % for peripheral arterial disease. Patients with a high foot risk level had more consultations in PC Nursing for foot-related issues (2022 y 2023; p=<0.001). The number of hospitalization days in 2022 was also higher in patients with a high foot risk. Patients with diagnosed neuropathy consistently utilized healthcare services more frequently than those with undiagnosed or no neuropathy across most categories.</p><p><strong>Conclusion: </strong>Patients with a high foot risk level consume more healthcare resources. Early detection and management of diabetic foot is crucial to avoid underdiagnosis, optimize resource use, and prevent serious complications.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142901553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jordan Khorsandi, Daniel Kraversky, Jack Martinyan, Prashant Parekh, Grettel Castro, Noël Barengo
{"title":"Association between insurance status and prevalence of diabetic retinopathy in patients with diabetes in the United States from 2011 to 2020.","authors":"Jordan Khorsandi, Daniel Kraversky, Jack Martinyan, Prashant Parekh, Grettel Castro, Noël Barengo","doi":"10.1016/j.pcd.2024.12.007","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.007","url":null,"abstract":"<p><strong>Aim: </strong>To determine whether an association exists between health insurance and diabetic retinopathy (DR) prevalence in adults with diabetes.</p><p><strong>Methods: </strong>An analytical cross-sectional study was conducted utilizing the National Health and Nutrition Examination Survey database. 4530 Patients aged ≥ 18 with diabetes from 2011 to 2020 with various insurance types (no insurance, private, Medicare, Medicaid, or other) were evaluated for prevalence of DR, including covariates. Unadjusted and adjusted logistic regression analysis were conducted to calculate odds ratios (OR) and 95 % confidence intervals (CI).</p><p><strong>Results: </strong>There was no significant association between insurance status and DR prevalence when adjusting for confounders. OR for DR in patients without insurance, Medicare, Medicaid, or other insurance compared to those with private insurance were 1.13 (95 % CI 0.74-1.71), 0.78 (95 % CI 0.54-1.13), 1.20 (95 % CI 0.80-1.81), and 0.81 (95 % CI 0.47-1.37) respectively. However, factors like age ≥ 65 and use of diabetes medication were associated with reduced DR prevalence.</p><p><strong>Conclusion: </strong>Although insurance status alone does not have an association with the prevalence of DR, this study highlights several confounding variables that potentially influence previously reported associations between insurance status and DR.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ibrahim Zaganjor, Ryan Saelee, Yoshihisa Miyamoto, Fang Xu, Meda E Pavkov
{"title":"Pain management and social functioning limitations among adults with chronic pain by diabetes status: National Health Interview Survey, United States, 2019-2020.","authors":"Ibrahim Zaganjor, Ryan Saelee, Yoshihisa Miyamoto, Fang Xu, Meda E Pavkov","doi":"10.1016/j.pcd.2024.12.008","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.008","url":null,"abstract":"<p><strong>Aims: </strong>This study aims to describe pain management technique usage and social functioning limitations among adults with chronic pain by diabetes status.</p><p><strong>Methods: </strong>The 2019 and 2020 National Health Interview Survey data were pooled to complete this analysis. Use of the following techniques in the past 3 months were measured: 1) prescription opioids; 2) physical, rehabilitative, or occupational therapy; 3) talk therapies; 4) chiropractic care; 5) yoga, Tai Chi, or Qi Gong; 6) massage; and 7) relaxation techniques. The social functioning limitations assessed were: 1) doing errands alone; 2) participating in social activities; and 3) work limitations. Weighted prevalence and 95 % confidence intervals (CIs) were estimated for each outcome by diabetes status. Logistic regression was used to estimate age- and sex-adjusted odds ratios (aORs) to assess differences by diabetes status.</p><p><strong>Results: </strong>Adults with diabetes and chronic pain were more likely to use prescription opioids (aOR: 1.4; 95 % CI: 1.2, 1.6) but less likely to use various nonpharmacological techniques than those without diabetes. Additionally, adults with diabetes and chronic pain were more likely to report each social functioning limitation than those without diabetes.</p><p><strong>Conclusions: </strong>Results suggest adults with diabetes and chronic pain may be missing beneficial opportunities to manage pain.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yoo Jin Um, Ho Kim, Joohon Sung, Yoo Hyun Um, Sung-Il Cho
{"title":"Prevalence of prediabetes according to sleep apnea status.","authors":"Yoo Jin Um, Ho Kim, Joohon Sung, Yoo Hyun Um, Sung-Il Cho","doi":"10.1016/j.pcd.2024.12.004","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.004","url":null,"abstract":"<p><strong>Aim: </strong>The association between obstructive sleep apnea (OSA) and prediabetes using the STOP-Bang questionnaire remains unknown. We aimed to investigate the prevalence of prediabetes among people based on their sleep apnea status.</p><p><strong>Methods: </strong>This cross-sectional study included 10131 Korean adults without diabetes with information of STOP-Bang scores, drawn from the dataset of the Korea National Health and Nutrition Examination Survey 2019-2021. Prediabetes was defined in three subsets: only by fasting blood glucose (FBG) (FBG 100-125 mg/dL, HbA1c <5.7 %), only by HbA1c (FBG <100 mg/dL, HbA1c 5.7-6.4 %) or by both. We used multivariable logistic regression to assess the odds ratio (OR) and 95 % confidence intervals (CIs) for prediabetes.</p><p><strong>Results: </strong>A total of 3828 subjects reported a STOP-Bang score of ≥ 3, which shows increased risk of OSA. Multivariable-adjusted OR (95 % CI) showed that a STOP-Bang score ≥ 3 was associated with prediabetes meeting both FBG and HbA1c criteria (OR 1.06; 95 % CI 1.01-1.12). This association was statistically significant among women, particularly postmenopausal women (OR 1.20, 95 % CI 1.10-1.30; OR 1.21, 95 % CI 1.11-1.32, respectively).</p><p><strong>Conclusion: </strong>In Korean general population, a significant correlation between higher OSA risk and prediabetes was observed, especially in postmenopausal women.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Angela L Beros, John D Sluyter, Alun D Hughes, Bernhard Hametner, Siegfried Wassertheurer, Robert Scragg
{"title":"Positive association of oscillometrically estimated baseline arterial stiffness with incident diabetes and prediabetes: A large population-based cohort study.","authors":"Angela L Beros, John D Sluyter, Alun D Hughes, Bernhard Hametner, Siegfried Wassertheurer, Robert Scragg","doi":"10.1016/j.pcd.2024.12.006","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.006","url":null,"abstract":"<p><strong>Aims: </strong>This large population-based study aimed to investigate whether arterial stiffness, assessed oscillometrically, was associated with incident diabetes/prediabetes.</p><p><strong>Methods: </strong>The study sample comprised 4240 participants from the Vitamin D Assessment (ViDA) Study (mean±SD age = 66 ± 8). Arterial stiffness was assessed from 5 April 2011-6 November 2012 by way of aortic PWV (aPWV) and estimated carotid-femoral PWV (ecfPWV). Incident diabetes/prediabetes was determined by linkage to dispensed prescription and national hospital discharge registers. Cox proportional hazards regression was used to assess the risk of diabetes/prediabetes in relation to chosen arterial stiffness measures both overall and over quartiles.</p><p><strong>Results: </strong>During a mean±SD follow-up of 10.5 ± 0.4 years, 470 participants developed diabetes/prediabetes. Following adjustment for potential confounders, aPWV (hazard ratio (HR) per SD increase, 1.40, 95 % CI, 1.19-1.64) was associated with the incidence of diabetes. The risk of incident diabetes was, compared to the first quartile, higher in the fourth quartile of aPWV (HR, 1.98, 95 %CI, 1.26-3.11)(P<sub>trend</sub>=0.01).</p><p><strong>Conclusions: </strong>Arterial stiffness, as measured by aPWV may be a useful predictor of incident diabetes that can be utilized in clinical practice.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Trevor Lopatin, Kwame Sakyi, Bradley Kendall, George Grunberger, Joshua Haworth
{"title":"Standing balance impairment in persons with type 2 diabetes is predicted by peripheral neuropathy and vestibulopathy.","authors":"Trevor Lopatin, Kwame Sakyi, Bradley Kendall, George Grunberger, Joshua Haworth","doi":"10.1016/j.pcd.2024.12.003","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.003","url":null,"abstract":"<p><strong>Introduction: </strong>The three main sensory complications of Type 2 Diabetes are diabetic peripheral neuropathy (DPN), diabetic retinopathy (DR), and diabetic vestibulopathy (DV). Current screening for these has been found to be insufficient, and balance testing may be a way to improve screening practices. This study aims to assess if the presence of sensory complications can be used to predict balance scores.</p><p><strong>Methods: </strong>52 participants with T2D were recruited for this study. Participants anthropometric measures, demographic, socioeconomic, and information related to the participants T2D were recorded. Participants completed the modified Clinical Test of Sensory Integration in Balance (mCTSIB) and scores were recorded. Bivariate analysis was conducted on all variables related to mCTSIB total balance scores. A multivariable linear regression model was created using mCTSIB total scores as the outcome and T2D sensory complications as the predictor while controlling for sex and age.</p><p><strong>Results: </strong>Bivariate analysis revealed significant (p < 0.05) associations between mCTSIB total scores and T2D sensory complications, education, employment, annual income, and age. The final multivariate linear regression model was found to be significant (Adj R<sup>2</sup> = 0.45, p < 0.01). This model showed that those with DPN (β = 121.03 cm, CI = 77.71-164.35, p < 0.01) or DV (β: 60.65, CI = 5.17-116.13, p = 0.04) had significantly higher balance scores compared to those that did not have a sensory complication, adjusting for sex and age.</p><p><strong>Conclusion: </strong>Sensory complications of T2D have the potential to predict balance scores and provides the first evidence that balance assessments may also be able to screen for DPN and DV.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Incidence and factors associated with new depressive episodes in adults with newly treated type 2 diabetes: A cohort study.","authors":"Jessica Kuntz, Candace Necyk, Scot H Simpson","doi":"10.1016/j.pcd.2024.12.001","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.12.001","url":null,"abstract":"<p><strong>Aims: </strong>Several methods are available to help identify people with depression; however, there is little guidance on when to start screening. This study estimated the incidence of new depressive episodes and identified factors associated with onset in adults with newly treated type 2 diabetes.</p><p><strong>Methods: </strong>Administrative health data from Alberta, Canada was used to identify people starting metformin between April 2011 and March 2015. People with a history of depression before metformin initiation were excluded. Person-time analysis was used to calculate the incidence rate of new depressive episodes over the next 3 years, stratified by sex, age, and year. Multivariable logistic regression was used to identify factors independently associated with a new depressive episode.</p><p><strong>Results: </strong>42,694 adults initiated metformin; mean age 56 years, 38 % female. A new depressive episode occurred in 2752 (6 %) individuals, mean time to onset was 1.4 years and overall incidence rate was 22.3/1000 person-years. Factors associated with a new depressive episode were female sex, younger age, previous mental health conditions, frequent healthcare utilization, and multiple comorbid conditions.</p><p><strong>Conclusions: </strong>Screening for depression should begin within 1-2 years of metformin initiation and focus on females, those < 55 years old, those with a history of mental health conditions, and those with multiple comorbid conditions.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}